HCP/Customer Strategy Lead at Bristol-Myers Squibb

Budapest, Budapest, Hungary

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Strong scientific experience with a track record of leading and executing HCP-focused strategies
Experience in Cardiovascular preferred
Ability to work in Matrix and have managed one or more direct reports
Knowledge of HCP customer journeys, preferences, and needs within Cardiovascular
Fluency in interpreting analytical models and ability to translate analytics from BI&A teams into actionable strategies
Familiarity with omnichannel strategy and modular content production
Ability to navigate [incomplete in JD]

Responsibilities

Builds and delivers the TA strategy and plan that drives success
Owns the end-to-end HCP customer journey and acts as a key partner for the Brand Lead in defining educational needs and driving scientific initiatives to secure proper understanding of the disease and treatment options
Interacts with HCP for defined activities in alignment to strategic needs
Fosters collaborative working relationships with the Brand Lead and cross-functional brand team members to ensure creation of a unified brand strategy
Integrates insights from advanced analytics models and market research to develop HCP customer journey, customer segments and create tailored omnichannel strategies, optimizing channel selection, actively working with Brand Lead, Omnichannel strategist and all team stakeholders
Leverages omnichannel capabilities and rapid, personalized content creation processes to enhance customer experience and engagement
Utilizes engagement and performance feedback to improve customer engagement strategies and campaigns
Defines KPIs of success for the HCP customer segment activities and for the Omnichannel interactions
Secures reporting of focused and On label HCP interactions in line with Brand Lead
Collaborates with Access, Commercial and Medical teams to translate insights into compliant Brand strategic imperatives and strategic initiatives
Plans and delivers content across personal and non-personal channels in alignment with brand goals
Works with analytics and market research teams to define and implement performance metrics
Sets up strategies and executes key projects in the TA to secure Scientific Leadership
Champions modular content production and omnichannel deployment in collaboration with Omnichannel COE, BI&A, and agencies, focusing on nonpromotional initiatives

Skills

HCP Strategy

Customer Journey Mapping

Strategy Development

Insights Analytics

Cross-Functional Collaboration

Brand Strategy

Disease Strategy

Scientific Engagement

Educational Initiatives

Tactic Execution

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free